Tuesday, 02 January 2024 12:17 GMT

Breakout Buys: Tata Steel, BSE, Vedanta And Sun Pharma Poised For Upside


(MENAFN- AsiaNet News)

Market analysts have identified multiple breakout opportunities across key sectors, including metals, pharma, and capital market stocks. SEBI-registered analyst Financial Sarthis flagged two strong breakout stocks to watch: Vedanta and Sun Pharma. While Palak Jain is bullish on BSE and Tata Steel. 

Let's take a look at their stock recommendations: 

Tata Steel

Tata Steel has seen a resistance breakout with substantial volumes after a tight consolidation range. It is now showing new bullish momentum and a clear entry above 176.

Palak Jain believes that its strong brand backing, improving business outlook, stable earnings, and positive sector tailwinds hold well for the stock going forward. Additionally, the risk-reward is attractive from a breakout, with a stop firmly below the recent support zone.

She advised buying Tata Steel above ₹176, with a stop loss at ₹165 for target prices of ₹181, ₹187, and ₹197.

Bombay Stock Exchange (BSE)

Jain noted a flag and pole pattern breakout in BSE above ₹2,335 on the weekly chart with strong volumes. The stock is showing a fresh uptrend after a healthy correction phase. Flagpole breakout flips resistance to support, providing a clean swing setup opportunity with clear targets and well-defined stoploss for risk control, she added.

Jain advised buying BSE above ₹2,335, with a stop loss at ₹2,202 for target prices of ₹2,405, ₹2,475, and ₹2,615.

Vedanta

Financial Sarthis noted a flat horizontal breakout in Vedanta. The strong surge in volumes confirmed strong buying interest in the utilities space. They see a gap fill towards ₹494-₹496 and then towards ₹510-₹515 levels. 

 Sun Pharma

Financial Sathis also flagged a flat horizontal breakout in Sun Pharma, supported by huge volume buying. They believe the stock could now test ₹1,690 & ₹1,740 with support at ₹1,630.

For updates and corrections, email newsroom[at]stocktwits[dot]com.

MENAFN10102025007385015968ID1110176845



Legal Disclaimer:
MENAFN provides the information “as is” without warranty of any kind. We do not accept any responsibility or liability for the accuracy, content, images, videos, licenses, completeness, legality, or reliability of the information contained in this article. If you have any complaints or copyright issues related to this article, kindly contact the provider above.